Companies such as PepsiCo and Mondelēz haven’t seen an impact on business, while Healthy Choice maker Conagra sees the ...

I've gained a lot of weight here because of my back,” he said to Khloe and Kris Jenner, who were visiting his house at the ...

Last week, the US Food and Drug Administration (FDA) announced the end of a years-long shortage of semaglutide injection products — a ...

New diabetes medications are pressuring Medicare Part D financially as they drive up prescription drug costs amid rising ...

It’s normal to have lots of questions when you start a new prescription medication. Whether you can drink alcohol might be at ...

In her last week at AdExchanger, Senior Editor Alyssa Boyle reflects on three years of change, and stasis, in the CTV space. Then, how Ozempic is changing the marketing world.

Scott Disick copped to taking Mounjaro—an antidiabetic medication commonly used for weight loss—to drop the pounds after he ...

In February 2025, a rumor spread online that Elon Musk, the technology mogul and public face of the new Department of ...

Drug compounders aren’t ready to give up their ability to produce off-brand versions of Novo Nordisk’s weight-loss drug ...

The number of teens and young adults taking GLP-1 drugs has increased by 594 percent—but scientists are still trying to ...

Hims & Hers stock drops 26% as FDA resolves semaglutide shortage, threatening GLP-1 revenue. Click here to find out why HIMS ...

We recently published an article titled Two of 10 Worst-Performing Stocks Fall to All-Time Lows on Tuesday. In this article, ...